EUVIMED · CrossrefJournal
JAMA Dermatology
ISSN 2168-6068 · American Medical Association (AMA)
Latest articles
Scleromyxedema
Evaluation of Permethrin, Sulfur, and Benzyl Benzoate for Scabies Management in Infants and Toddlers
Changes in Smoking Intensity and the Risk of Psoriasis Development
Clinical Frequency and Characteristics of Peripheral Neuropathy in Dermatomyositis
Regarding the German Melanoma Screening Program Mortality—Reply
Regarding the German Melanoma Screening Program and Mortality
Low Disease Activity and Drug-Free Remission in Anti- MDA5 Dermatomyositis
Errors in Abstract, Text, Figure 2, and Supplement 1
Rethinking Low Disease Activity in Atopic Dermatitis—Reply
Clinical Characteristics, Etiologic Associations, and Treatment Outcomes of Pernio
Rethinking Low Disease Activity in Atopic Dermatitis
Autoinflammatory Syndromes—Recognizing Autoinflammatory Diseases in Dermatology
Tuberculosis Verrucosa Cutis With Chronic Lymphedema
Diffuse Lip Swelling and Oral Nodules in an Adolescent
Prevalence of Chronic Hand Eczema in Adults
Incidence of Cancer in Morphea and Systemic Sclerosis
Errors in Figure 2 and the Methods
Efficacy and Safety of Brepocitinib in Cutaneous Sarcoidosis
Intravascular Large B-Cell Lymphoma
Routine Clinical Nemolizumab Use Before or After Cutaneous T-Cell Lymphoma Diagnosis
Ultrasonography and International Perspectives on Imaging Consensus for Cutaneous Squamous Cell Carcinoma—Reply
Ultrasonography and International Perspectives on Imaging Consensus for Cutaneous Squamous Cell Carcinoma
End-of-Dose Effect as a Guide for Biologic Optimization in Hidradenitis Suppurativa
Errors in the Methods, Results, and Table 2
Cutaneous Lymphoma International Prognostic Index and Risk Stratification in Advanced Mycosis Fungoides and Sézary Syndrome
Global Disparities in Access to Dermatological Care
Skin-Specific Outcomes of Brepocitinib in Patients With Dermatomyositis
BCMA-Targeted T-Cell Engager Therapy for Refractory Pemphigus
Best Practices for Managing Pseudofolliculitis Barbae
EUVIMED